title: Muscarinic-receptor functioning in tracheas from normal and ovalbumin-sensitive guinea pigs.
abstract: Responses to bilateral vagal nerve stimulation, to field stimulation, and to exogenous methacholine and histamine were compared in tracheas isolated from (a) saline injected (i.p.) and saline-aerosol exposed guinea pigs (control), (b) ovalbumin-sensitized and saline-aerosol exposed (sensitized) guinea pigs, and (c) ovalbumin-sensitized and 2% ovalbumin-aerosol exposed (challenged) guinea pigs. Tracheal pressor responses (cmH2O; 1 cmH2O = 98.1 Pa) to nerve and field stimulation, and maximal responses to methacholine and histamine were significantly increased in animals from group c compared with groups a and b. Dose-response lines in response to the two agonists, expressed as percent maximal contraction, did not differ among the groups. The M1 antagonist pirenzepine (0.1-10 nM) selectively reduced responses to nerve stimulation in all three groups. The M2 antagonist gallamine potentiated responses to nerve or field stimulation in all three groups. We conclude that M1, M2, and M3 muscarinic receptor functioning is similar in control and ovalbumin-sensitized guinea pigs. Changes in post-receptor transduction mechanisms may mediate the increased responsiveness noted in animals from group c.
authors.affiliation: Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Canada.
authors.forename: Z J
authors.initials: ZJ
authors.lastname: Yang
authors.forename: D F
authors.initials: DF
authors.lastname: Biggs
mesh_terms: D000336:Aerosols; D000818:Animals; D001249:Asthma / Q000503:physiopathology; D001627:Bethanidine / Q000494:pharmacology; D004558:Electric Stimulation; D005260:Female; D005703:Gallamine Triethiodide / Q000494:pharmacology; D006168:Guinea Pigs; D006632:Histamine / Q000494:pharmacology; D006967:Hypersensitivity / Q000378:metabolism*; D066298:In Vitro Techniques; D007213:Indomethacin / Q000494:pharmacology; D008688:Methacholine Compounds / Q000494:pharmacology; D010047:Ovalbumin / Q000276:immunology*; D010890:Pirenzepine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011976:Receptors, Muscarinic / Q000502:physiology*; D014132:Trachea / Q000294:innervation / Q000378:metabolism*; D015016:Yohimbine / Q000494:pharmacology
chemical_list: D000336:Aerosols; D008688:Methacholine Compounds; D011976:Receptors, Muscarinic; D015016:Yohimbine; D010890:Pirenzepine; D006632:Histamine; D010047:Ovalbumin; D011433:Propranolol; D005703:Gallamine Triethiodide; D001627:Bethanidine; D007213:Indomethacin